Niranjan Y. Sardesai
Vorstandsvorsitzender bei Geneos Therapeutics, Inc.
Aktive Positionen von Niranjan Y. Sardesai
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Vorstandsvorsitzender | 01.01.2017 | - |
| Gründer | 01.01.2017 | - | |
| Präsident | 01.01.2017 | - |
Karriereverlauf von Niranjan Y. Sardesai
Ehemalige bekannte Positionen von Niranjan Y. Sardesai
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Geschäftsführer | 01.06.2009 | 21.02.2019 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.06.2009 | 05.01.2012 | |
VGX Pharmaceuticals LLC
 VGX Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology VGX Pharmaceuticals LLC develops pharmaceuticals. The company was founded by J. Joseph Kim and is headquartered in Blue Bell, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2007 | 01.11.2007 |
| Nvision Consulting, Inc. | Gründer | 01.06.2005 | 01.09.2006 |
| Präsident | - | 01.09.2006 | |
Fujirebio Diagnostics, Inc.
 Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2005 | 01.12.2005 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Niranjan Y. Sardesai
| California Institute of Technology | Doctorate Degree |
| Indian Institute of Technology Bombay | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 9 |
| Indien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| President | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Nvision Consulting, Inc. | |
Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Health Technology |
VGX Pharmaceuticals LLC
VGX Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology VGX Pharmaceuticals LLC develops pharmaceuticals. The company was founded by J. Joseph Kim and is headquartered in Blue Bell, PA. | Health Technology |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Health Technology |
- Börse
- Insiders
- Niranjan Y. Sardesai
- Erfahrung